Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection

Use of interleukin-2 (IL-2) receptor-specific agents to treat allograft rejection. 1999.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.